GH Research
GHRS
21.06
-0.46
-2.14%
GH Research
US · GHRS
#2969 by market cap
Listed 2021
21.06
-0.46
-2.14%
Live - 5344 symbols - heartbeat 112s ago
· 2026-10-08 07:39
Pre-market
21.04
-0.09%
After-hours
21.00
-0.28%
- Market cap
- 1.45B
- P/E (TTM)i
- -21.27
- P/Bi
- 4.02
- EPSi
- -0.79
- Div yieldi
- 0.00%
- 52W posi
- 46%
Reader sentiment
Are you bullish or bearish on GHRS?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 7 years
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 14.00K | 108.00K | 6.54M | 10.06M | 11.12M | 15.00M | 21.65M |
| Research & development | 296.00K | 338.00K | 8.55M | 20.48M | 29.82M | 35.02M | 38.77M |
| Operating profit | -310.00K | -446.00K | -15.10M | -30.68M | -41.22M | -50.25M | -60.68M |
| Pretax profit | -310.00K | -446.00K | -9.20M | -22.46M | -35.59M | -38.96M | -48.26M |
| Tax | -- | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | -310.00K | -446.00K | -9.20M | -22.46M | -35.59M | -38.96M | -48.26M |
| Basic EPS | 0 | 0 | 0 | 0 | -1 | -1 | -1 |
| Diluted EPS | -0.01 | -0.01 | -0.21 | -0.43 | -0.68 | -0.75 | -0.79 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 4.88M | 5.75M | 5.92M | 5.25M | 6.37M | 7.06M |
| Research & development | 7.85M | 8.96M | 10.57M | 11.39M | 12.38M | 12.40M |
| Operating profit | -12.75M | -14.69M | -16.54M | -16.70M | -18.75M | -19.45M |
| Pretax profit | -10.81M | -9.29M | -14.02M | -14.14M | -18.97M | -15.15M |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | -10.81M | -9.29M | -14.02M | -14.14M | -18.97M | -15.15M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.19 | -0.15 | -0.23 | -0.23 | -0.31 | -0.23 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | 504.00K | 5.91M | 279.84M | 168.54M | 164.09M | 154.23M | 285.98M |
| Cash & ST investments | 498.00K | 5.90M | 276.78M | 165.96M | 161.56M | 149.32M | 280.71M |
| Inventory | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 504.00K | 5.91M | 279.92M | 254.36M | 226.30M | 188.27M | 288.23M |
| Total current liabilities | 104.00K | 246.00K | 2.75M | 4.55M | 6.70M | 8.95M | 8.38M |
| Short-term debt | -- | -- | -- | -- | 343.00K | 255.00K | 365.00K |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 104,000.00 | 246,000.00 | 2,749,000.00 | 4,546,000.00 | 7,332,000.00 | 9,322,000.00 | 8,527,000.00 |
| Total equity | 400.00K | 5.67M | 277.18M | 249.82M | 218.97M | 178.95M | 279.70M |
| Retained earnings | -389.00K | -835.00K | -10.04M | -32.49M | -67.94M | -106.45M | -154.43M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 294.67M | 293.88M | 294.79M | 285.98M | 272.23M | 368.82M |
| Cash & ST investments | 291.35M | 291.54M | 288.51M | 280.71M | 267.33M | 362.65M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 320.45M | 313.43M | 302.02M | 288.23M | 275.27M | 372.35M |
| Total current liabilities | 9.92M | 9.97M | 10.41M | 8.38M | 11.82M | 12.85M |
| Short-term debt | 336.00K | 364.00K | 365.00K | 365.00K | 357.00K | 354.00K |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 10,240,000.00 | 10,249,000.00 | 10,625,000.00 | 8,527,000.00 | 11,890,000.00 | 12,859,000.00 |
| Total equity | 310.21M | 303.18M | 291.40M | 279.70M | 263.38M | 359.49M |
| Retained earnings | -117.04M | -126.27M | -140.29M | -154.43M | -173.23M | -187.84M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -289.00K | -330.00K | -15.28M | -26.20M | -33.34M | -42.29M | -43.55M |
| Depreciation & amortization | 0 | 0 | 19.00K | 47.00K | 315.00K | 315.00K | 335.00K |
| Free cash flow | -289.00K | -330.00K | -15.39M | -26.27M | -33.44M | -42.33M | -43.67M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 797.00K | 5.50M | 309.20M | 0 | 15.00K | 0 | 150.00M |
| Ending cash balance | 498.00K | 5.90M | 276.78M | 165.96M | 78.42M | 100.79M | 246.25M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -8.57M | -8.97M | -13.68M | -12.33M | -10.67M | -15.02M |
| Depreciation & amortization | 76.00K | 82.00K | 89.00K | 88.00K | 91.00K | 91.00K |
| Free cash flow | -8.58M | -9.03M | -13.72M | -12.35M | -10.73M | -15.04M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 150.00M | 0 | 0 | 0 | 72.00K | 117.97M |
| Ending cash balance | 244.95M | 253.87M | 249.65M | 246.25M | 242.65M | 345.05M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -77.50 | -14.70 | -6.51 | -8.52 | -15.18 | -19.58 | -21.04 |
| ROA %i | -61.51 | -13.90 | -6.44 | -8.41 | -14.81 | -18.80 | -20.26 |
| ROIC %i | -77.50 | -14.70 | -6.50 | -8.52 | -17.65 | -22.62 | -23.19 |
| 5-year avg ROE %i | -- | -- | -- | -- | -24.48 | -12.90 | -14.17 |
| EBIT margin %i | -- | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 4.85 | 24.03 | 101.80 | 37.07 | 24.49 | 17.23 | 34.13 |
| Quick ratioi | 4.79 | 23.99 | 100.70 | 36.53 | 24.15 | 16.87 | 33.65 |
| Debt / assetsi | -- | -- | -- | 0.00 | 0.43 | 0.33 | 0.18 |
| LT debt / equityi | -- | -- | -- | -- | 0.29 | 0.21 | 0.05 |
| Interest coveragei | -- | -- | -1,021.44 | -- | -563.87 | -810.69 | -1,377.80 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -16.20 | -16.35 | -17.86 | -21.04 | -19.67 | -18.79 |
| ROA %i | -15.65 | -15.76 | -17.11 | -20.26 | -18.94 | -18.16 |
| ROIC %i | -18.69 | -18.85 | -20.29 | -23.19 | -20.92 | -19.82 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 29.71 | 29.49 | 28.32 | 34.13 | 23.04 | 28.70 |
| Quick ratioi | 29.38 | 29.25 | 27.72 | 33.65 | 22.63 | 28.22 |
| Debt / assetsi | 0.21 | 0.21 | 0.19 | 0.18 | 0.16 | 0.10 |
| LT debt / equityi | 0.10 | 0.09 | 0.07 | 0.05 | 0.03 | 0.00 |
| Interest coveragei | -934.71 | -999.41 | -1,159.08 | -1,377.80 | -1,818.77 | -2,222.93 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Quote time 2026-10-08 07:39:09 · For reference only, not investment advice and not tailored to your situation.